We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Valeant Pharmaceuticals Faces New Investigation By SEC

Law360, Los Angeles (February 29, 2016, 7:31 PM EST) -- Valeant Pharmaceuticals International Inc. is under investigation by the U.S. Securities and Exchange Commission, the company said Monday, shortly after announcing its CEO’s return from medical leave, a generic-drug maker's challenge...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.